Cochlear CI632D dexamethasone-eluting electrode array

Investigational slim modiolar cochlear-implant electrode array designed to slowly elute dexamethasone in the cochlea after implantation to reduce inflammation and tissue response while supporting hearing outcomes in adults with sensorineural hearing loss.

Split out from the generic dexamethasone registry cluster because NCT06598059 is an industry-sponsored Cochlear device study of the investigational CI632D dexamethasone-eluting slim modiolar electrode array, not a generic standalone dexamethasone drug program. Public evidence in this pass is registry-only, so efficacy and market status should not be inferred beyond the active pivotal study listing.